Fajri Gafar
8PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 27, 2026
Population Pharmacokinetic Modeling of Standard- and High-Dose Rifampicin for Tuberculosis Preventive Therapy in the 2R2 Randomized Controlled Trial.Fajri Gafar, Elin M Svensson, Vycke Yunivita
|Dec 18, 2025
Efficacy of isoniazid in paediatric tuberculosis: an individual participant data meta-analysis.Agathe Béranger, Belén P Solans, Ryo Miyakawa
|Sep 23, 2024
Clinical Features, Adverse Events and Treatment Outcomes of Multidrug/Rifampicin-resistant Tuberculosis in Children and Adolescents: An Eight-year Retrospective Cohort Study in Bandung, Indonesia.Heda M Nataprawira, Fajri Gafar, Chindy A Sari
|Nov 03, 2022
Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis.Fajri Gafar, Roeland E Wasmann, Helen M McIlleron
|Dec 15, 2021
Optimizing Antimicrobial and Host-Directed Therapies to Improve Clinical Outcomes of Childhood Tuberculous Meningitis.Fajri Gafar, Ben J Marais, Heda M Nataprawira
|Jun 29, 2021
Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis.Rovina Ruslami, Fajri Gafar, Vycke Yunivita
Pageof 2
Frequent Collaborators
2 joint publications
Chishala Chabala
1 joint publications
Taichi Ochi
1 joint publications
H Simon Schaaf
1 joint publications
Ben J Marais
1 joint publications
Ephrem Engidawork
1 joint publications
Anthony J Garcia-Prats
1 joint publications
Diana Gibb
1 joint publications
Stephen M Graham
1 joint publications
Estomih Mduma
1 joint publications
Stephanie Thee
